ArticleEClinicalMedicine2021

Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in China.

Hongrui Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.